Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term me [Metabolism]. Found 37 abstracts

no pagination
Crispen PL, Uzzo RG, Golovine K, Makhov P, Pollack A, Horwitz EM, Greenberg RE, Kolenko VM. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention. The Prostate. 2007 May;67(6):582-90.
Pugacheva EN, Jablonski SA, Hartman TR, Henske EP, Golemis EA. HEF1-dependent Aurora A activation induces disassembly of the primary cilium.[see comment]. Cell. 2007 Jun 29;129(7):1351-63.
Meropol NJ, Gold PJ, Diasio RB, Andria M, Dhami M, Godfrey T, Kovatich AJ, Lund KA, Mitchell E, Schwarting R. Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.[see comment]. Journal of Clinical Oncology. 2006 Sep;24(25):4069-77.
Robb VA, Astrinidis A, Henske EP. Frequent [corrected] hyperphosphorylation of ribosomal protein S6 [corrected] in lymphangioleiomyomatosis-associated angiomyolipomas.[erratum appears in Mod Pathol. 2006 Jun;19(6):889]. Modern Pathology. 2006 Jun;19(6):839-46.
Bookman MA. Gemcitabine monotherapy in recurrent ovarian cancer: from the bench to the clinic. International Journal of Gynecological Cancer. 2005 May;15 Suppl 1:12-7.
Cheng JD, Valianou M, Canutescu AA, Jaffe EK, Lee HO, Wang H, Lai JH, Bachovchin WW, Weiner LM. Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth. Molecular Cancer Therapeutics. 2005 Mar;4(3):351-60.
Chen ZS, Guo Y, Belinsky MG, Kotova E, Kruh GD. Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11). Molecular Pharmacology. 2005 Feb;67(2):545-57.
Gate L, Majumdar RS, Lunk A, Tew KD. Influence of glutathione S-transferase pi and p53 expression on tumor frequency and spectrum in mice. International journal of cancer. 2005 Jan;113(1):29-35.
Hayashi J, Stoyanova R, Seeger C. The transcriptome of HCV replicon expressing cell lines in the presence of alpha interferon. Virology. 2005 May 10;335(2):264-75.
Henske EP. Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond. Pediatric Nephrology. 2005 Jul;20(7):854-7.
Kruh GD. Ins and outs of taxanes.[comment]. Cancer Biology & Therapy. 2005 Sep;4(9):1030-2.
Tarn C, Godwin AK. Molecular research directions in the management of gastrointestinal stromal tumors. Current treatment options in oncology. 2005 Nov;6(6):473-86.
Wen L, Brill-Dashoff J, Shinton SA, Asano M, Hardy RR, Hayakawa K. Evidence of marginal-zone B cell-positive selection in spleen.[see comment]. Immunity. 2005 Sep;23(3):297-308.
Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, Erzberger JP, Serebriiskii IG, Canutescu AA, Dunbrack RL, Pehrson JR, Berger JM, Kaufman PD, Adams PD. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Developmental cell. 2005 Jan;8(1):19-30.
Adams GP, Shaller CC, Dadachova E, Simmons HH, Horak EM, Tesfaye A, Klein-Szanto AJ, Marks JD, Brechbiel MW, Weiner LM. A single treatment of yttrium-90-labeled CHX-A"-C6.5 diabody inhibits the growth of established human tumor xenografts in immunodeficient mice.[see comment]. Cancer Research. 2004 Sep;64(17):6200-6.
Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK, Testa JR. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene. 2004 Jul 29;23(34):5853-7.
Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Research. 2004 Feb;64(3):1181-9.
Badawi AF, Liu Y, Eldeen MB, Morrow W, Razak ZR, Maradeo M, Badr MZ. Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate. Carcinogenesis. 2004 Sep;25(9):1681-8.
Balogh GA, Russo IH, Russo J. Truncation of the mismatch repair protein PMS2 during the neoplastic transformation of human breast epithelial cells in vitro. International Journal of Oncology. 2004 Aug;25(2):381-7.
Cvetkovic D, Pisarcik D, Lee C, Hamilton TC, Abdollahi A. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer. Gynecologic Oncology. 2004 Dec;95(3):449-55.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term me [Metabolism]

me [Metabolism] Non-US Gov't Research Support ge [Genetics] pd [Pharmacology] Female Cell Line aa [Analogs & Derivatives] ph [Physiology] de [Drug Effects] Biological) 0 (Tumor Markers dt [Drug Therapy] Biological Tumor Markers ai [Antagonists & Inhibitors] pa [Pathology] Mice Phosphorylation Ovarian Neoplasms ch [Chemistry] en [Enzymology] Tumor Cell Line Apoptosis bi [Biosynthesis] Signal Transduction Antineoplastic Agents Isoenzymes Immunohistochemistry cy [Cytology] Enzymologic Gene Expression Regulation ad [Administration & Dosage] Breast Neoplasms Male 0 (Isoenzymes) 0 (Antineoplastic Agents) 0 (Transcription Factors) Mutation Time Factors Transcription Factors Comparative Study Neoplasm) 0 (DNA EC 2-7-1-137 (1-Phosphatidylinositol 3-Kinase) Molecular Models 0 (Cell Cycle Proteins) Western Blotting tu [Therapeutic Use] Drug Dose-Response Relationship EC 2-7-1-37 (Protein-Serine-Threonine Kinases) Angiomyolipoma Rats an [Analysis] Protein Kinases im [Immunology] Prostaglandin-Endoperoxide Synthase 0 (Enzyme Inhibitors) Proto-Oncogene Proteins EC 1-14-99-1 (Prostaglandin-Endoperoxide Synthase) Gene Expression 363-24-6 (Dinoprostone) EC 2-7-1 (mTOR protein) Enzyme Inhibitors NIH Research Support-Extramural Deoxycytidine 0 (Proto-Oncogene Proteins) Neoplasm DNA Transfection Repressor Proteins Cell Division US Gov't Support-PHS Phenotype Cell Cycle Neoplasm Proteins 0 (Neoplasm Proteins) ras Proteins Messenger) 0 (RNA Dinoprostone 951-77-9 (Deoxycytidine) EC 2-7-1-37 (Protein Kinases) Messenger RNA Protein-Serine-Threonine Kinases Neoplastic Gene Expression Regulation Cell Cycle Proteins Flow Cytometry 1-Phosphatidylinositol 3-Kinase 0 (macroH2A histone) EC 2-7-1 (aurora kinase) 0 (Sulfonamides) 0 (Chromones) Local Neoplasm Recurrence 0 (Immunotoxins) Viral Gene Expression Regulation 0 (Autoantibodies) 2-diamine (N-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1 0 (DNA-Binding Proteins) Glutathione Transferase Cell Surface) 0 (Receptors Dipeptidyl Peptidases 70-kDa Ribosomal Protein S6 Kinases B-Lymphocytes 103882-84-4 (gemcitabine) df [Deficiency] Antitumor Drug Screening Assays 684-93-5 (Methylnitrosourea) Middle Aged EC 1-14-99 (cyclooxygenase 2) Immunoprecipitation Cilia Genotype Gene Expression Profiling Vitamin E Transcription Factor AP-1 0 (Neuropeptides) Cisplatin 33069-62-4 (Paclitaxel) 0 (Indoles) Survival Analysis Isothiocyanates 0 (Yttrium Radioisotopes) Prostaglandin D2 Cell Proliferation human) 0 (PLAGL1 protein Non-Histone Chromosomal Proteins Sirolimus Adult EC 2-7-1 (protein kinase C alpha) Dosage Compensation (Genetics) Radioimmunotherapy Carcinoma Bile Acids and Salts Disease Susceptibility Disease-Free Survival Base Pair Mismatch Immunoenzyme Techniques 0 (Nuclear Proteins) Prostate 0 (Biological Markers) Enzyme Activation Cell Count 72025-60-6 (Leukotriene C4) Nuclear Proteins Cell Differentiation Thy-1 Antigens LLC-PK1 Cells Tissue Distribution erbB-2 Receptor 152459-95-5 (imatinib) Signal Transducing Adaptor Proteins Transgenic Mice Biological Markers Spleen 0 (Anticarcinogenic Agents) Sodium-Independent) 0 (Organic Anion Transporters
Last updated on Thursday, April 02, 2020